Search results

7 items
  1. The WHO’s First-Ever Critical Review of Cannabis

    • John Walsh, Martin Jelsma, Tom Blickman, David Bewley-Taylor
    19 March 2019
    Policy briefing

    The World Health Organization’s (WHO) Expert Committee on Drug Dependence (ECDD or Expert Committee) released in January 2019 the outcomes of the first-ever critical review of cannabis, recommending a series of changes in the current scheduling of cannabis-related substances under the UN drug control conventions.

  2. Canada’s next steps on cannabis and the UN Drug Treaties

    David Bewley-Taylor, Tom Blickman, Martin Jelsma, John Walsh
    03 April 2018
    Opinion

    Ever since the introduction of Bill C-45, questions have been swirling concerning Canada’s position relative to the UN drug control conventions: conventions to which Canada is a party and that, crucially, prohibit the creation of regulated markets for the recreational use of cannabis.

  3. Balancing Treaty Stability and Change

    • Martin Jelsma, Neil Boister, David Bewley-Taylor, Malgosia Fitzmaurice, John Walsh
    15 March 2018
    Policy briefing

    Legal tensions are growing within the international drug control regime as increasing numbers of member states move towards or seriously consider legal regulation of the cannabis market for non-medical purposes. Amongst reform options not requiring consensus, inter se modification appears to be the most ‘elegant’ approach and one that provides a useful safety valve for collective action to adjust a treaty regime arguably frozen in time.

  4. Yes, legalizing marijuana breaks treaties. We can deal with that.

    John Walsh, Tom Blickman, Martin Jelsma, David Bewley-Taylor
    10 January 2018
    Opinion

    Buzzing in the background of Canada’s debate on cannabis legalization is the issue of the three UN drug control treaties, and what to do with them.

  5. Will UNGASS 2016 be the beginning of the end for the ‘war on drugs’?

    Ann Fordham, Martin Jelsma
    17 March 2016
    Opinion

    Held this April, will the United Nations General Assembly Special Session be the turning point for the international drug control system?

  6. The ketamine controversy, continued

    Martin Jelsma
    06 March 2015
    Opinion

    The Commission on Narcotic Drugs (CND) in Vienna will decide next week between two opposite proposals by China and the WHO about international control of ketamine, an essential anaesthetic in human and veterinary medicine. China originally proposed bringing ketamine under the 1971 Convention’s most severe control regime of Schedule I, which would dramatically affect its availability for surgery in poor rural settings and emergency situations. The WHO Expert Committee reviewed all the evidence and advised against any international control of ketamine, arguing it would trigger a public health disaster.

  7. Into the breach: Drugs, control, and violating bad laws in good ways

    Rick Lines
    27 November 2014
    Opinion

    An October statement on drug control from the US State Department has prompted much comment and speculation at home and abroad. Delivered by Ambassador William Brownfield, the ‘Brownfield Doctrine’, as it has been named by some commentators, lays out a four pillar approach the United States will follow in matters of international drug control.